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Mycobacterium tuberculosis-specific antibodies (immunoglobulin M [IgM], IgE, IgG, and IgG subclasses)
were determined in 164 tuberculosis patients (pulmonary involvement, n 5 135; lymph node involvement, n 5
29), 59 healthy household contacts (HC), and 51 healthy endemic donors (EC) by a quantitative enzyme-linked
immunosorbent assay for reactivity with culture filtrate. Among the isotypes, significant differences between
tuberculosis patient groups with either pulmonary or lymph node involvement and healthy control groups (HC
and EC) were detected only for IgG (P < 0.001) and IgG1 (P < 0.001) antibodies. Pulmonary patients also
showed a significant difference with IgM (P < 0.01) and IgE (P < 0.05) antibodies. HC showed elevation of only
IgM antibodies compared with EC, indicating that IgM antibodies may be an indicator of recent infection with
M. tuberculosis. These results suggest that the switching of IgM antibody response to IgG1 is a critical event in
disease progression. Polyclonal IgG1, IgG3, and IgE antibodies also showed significant elevation (P < 0.05) in
patients compared with EC. A strong correlation (rho 5 0.254; P < 0.003) was observed between M. tuberculosis-specific IgG1 and polyclonal IgG1 in patients, suggesting that activations of antigen-specific and polyclonal antibodies are related events. No correlation was found between IgG1 antibodies and purified protein
derivative skin test results. Since IgG1 antibody responses to culture filtrate are present only after disease
establishment, IgG1 responses could provide a useful diagnostic marker of disease.
dresses the relationship between antibody isotypes (IgM, IgG,
IgG subclass, and IgE antibodies) and the disease severity in
pulmonary disease as well as the effect of localization of disease in different compartments (lymph node versus lung). The
most significant antibody response in tuberculosis patients was
observed for IgG1, which was raised irrespective of disease
localization compared with that in healthy controls (household
contacts [HC] and endemic controls [EC]). None of the other
IgG subclasses showed a similar relationship with established
disease.

Disease localization and protective immunity in mycobacterial disease are associated with T-cell responses, whereas humoral responses play little or no role in protection and are
considered to be of marginal importance in the outcome of
disease due to several intracellular pathogens, including tuberculosis and leprosy (reviewed in reference 20). The study of
antibody responses in tuberculosis has therefore focused
mainly on their usefulness as a diagnostic serological tool (3, 8,
15, 24), with little attention given to careful dissection of antibodies at the isotype and subclass level in relation to pathogenesis. Also unaddressed is the role of immunoglobulin G
(IgG) subclass response in relation to the extent of pulmonary
disease or to disease localization in different compartments.
Switching of antibody responses from IgM to one of the other
isotypes or IgG subclasses requires cytokines secreted by different subsets of T-helper cells (19, 27). The distribution of
IgG subclasses may therefore provide valuable insights into
differential T-cell activation and its relationship to disease progression in mycobacterial diseases. We have recently reported
that in leprosy, selective increases in IgG1 and IgG3 antibodies
to Mycobacterium leprae across the disease spectrum and both
subclasses showed a highly significant correlation with bacterial
load in the patients (12). The factors that regulate these IgG
subclasses are still not well characterized and could well determine the disease progression in other mycobacterial infections. We have therefore extended our studies to isotype and
IgG subclass responses in tuberculosis. The current study ad-

MATERIALS AND METHODS
Study subjects. Patients with active tuberculosis presenting at Masoomeen
Hospital between January 1991 and June 1994 (n 5 164; pulmonary involvement,
n 5 135; lymphadenitis [LN], n 5 23; LN with pulmonary involvement [LN/P],
n 5 6) were recruited for antibody studies. For the current study, patients with
pulmonary tuberculosis who were positive for acid-fast bacilli in sputum and/or
culture were included. LN patients showed characteristic caseous granuloma in
histology, but none stained positive for acid-fast bacilli. LN/P patients showed
histological evidence of caseous granuloma and radiological evidence of pulmonary involvement, and the sputum was also positive for acid-fast bacilli in five of
these six patients. LN patients included in this study were those that responded
to antituberculosis (ATT) chemotherapy. Pulmonary patients were further subdivided into moderate and advanced lung disease (PMD and PAD, respectively)
groups on the basis of the extent of lung tissue involvement. The PMD group had
disseminated lesions of moderate density that were confluent but not exceeding
more than a total of one lung volume, without or with a single cavity measuring
less than 4 mm and with miliary mottling; PAD lesions were more extensive than
PMD lesions, exceeding one lung volume and with multiple cavities. The majority of patients (87%) had received ,30 days of ATT chemotherapy. Fifty-nine
healthy HC of patients with cavitory lung disease were recruited to represent the
recently exposed population. Sera from 51 healthy donors who were employees
of Aga Khan University representing a broad socioeconomic background and
with no known direct exposure to active tuberculosis were included as EC.
Among the controls groups, 87% of HC and 56% of EC were tuberculin skin test
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RESULTS
Quantitation of IgG subclasses and IgE antibodies to M.
tuberculosis CF. (i) Development of a serum calibrator and
performance characteristics. Antigen-specific antibody responses in individual patients usually show log distribution,
and therefore, optical density readouts at a single dilution do
not allow quantitative assessment of differences between
groups. To overcome this limitation, we developed a reference
serum calibrator for each of the isotypes and IgG subclasses
except IgG4 and IgE, since antibodies in these two isotypes did
not show log distribution when screened at a 1:10 dilution.
Independent serum pools were generated by pooling sera with
high titers for either IgM, IgG, or IgG subclass antibodies
against CF. These pools were assigned arbitrary units of activity, with 1 U being equivalent to an optical density of ;0.1.
Dose-response curves for IgG and IgG1, IgG2, and IgG3 subclass antibodies against culture filtrate (after transformation of
the dose-response curve into units per milliliter) are shown in
Fig. 1. A four-degree polynomial equation was used to calculate the units in individual sera by using the midrange values.
Although this system allows us to determine quantitative log
differences among groups for an individual IgG subclass or
isotype, it still does not allow comparison of concentrations
between different IgG subclasses or isotypes which are related
to the sensitivity of detection of the different antibody probes.
(ii) Determination of antibody activity in sera of tuberculosis patients. Figure 2 shows the IgM, IgG, and IgE antibody
responses to M. tuberculosis CF in tuberculosis patients with
involvement of different compartments. Pulmonary patients
showed significantly elevated antibody responses in all three
isotypes (IgG, P , 0.001; IgM, P , 0.01; and IgE, P , 0.05)
compared with those in the healthy control group. Patients
with lymph node involvement showed significant differences
with IgM (P , 0.05) and IgG (P , 0.01) antibodies. Patients
with both lymph node and pulmonary involvement showed
raised IgG (P , 0.001) only. Interestingly, the only antibody
that was significantly elevated in the HC group was IgM (P ,
0.001). This could be due to current exposure to M. tuberculosis, as these were contacts of patients with cavitory lung
disease at the time of testing.
When IgG antibody was dissected into its subclasses (Fig. 3),
only IgG1 was significantly raised in all patient groups (LN, P
, 0.004; LN/P, P , 0.0004; PMD, P , 0.02; and PAD, P ,
0.004) compared with that in HC and EC. The only other
antibody which approached significance in the pulmonary involvement group was IgG3 (LN/P, P 5 0.06; PMD, P 5 0.05;
PAD, P 5 0.08). IgG2 and IgG4 did not show any consistent
pattern of elevation.
Quantitation of polyclonal antibodies. To see if the M. tuberculosis-specific IgG subclass response were related to differential polyclonal activation of these particular isotypes, we
also determined the concentrations of polyclonal antibodies
for each IgG subclass and IgE. Table 1 shows the concentration of polyclonal IgE and IgG subclass antibodies. Polyclonal
activation was selectively observed for IgG1, IgG3, and IgE in
patient groups compared with EC. The only exception was IgE
in the LN group, which was raised but did not achieve statistical significance. Interestingly, HC also showed selective polyclonal activation of the same antibodies (IgG1, IgG3, and IgE),
although antigen-specific IgG antibodies in these subclasses
could not be detected.
Correlation of antigen-specific IgG1 with polyclonal IgG1
and purified protein derivative (PPD) skin test. To see if
induction of antigen-specific responses were related to polyclonal activation or delayed-type hypersensitivity, which is an
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positive (.10.0 mm) at the time of immunological assessment. There was no
significant difference in the distribution of age and gender between patients and
healthy controls.
Serum. Five milliliters of blood collected from both patients and controls was
allowed to clot overnight at 48C. Serum was removed and centrifuged at 400 3
g for 15 min; the clear supernatant was distributed in 100-ml aliquots and frozen
at 2708C until use.
Antigens. Mycobacterium tuberculosis culture filtrate (CF) was a gift from H. J.
Kolk of The Royal Tropical Institute, Amsterdam, The Netherlands. Preparation
of this CF has been described previously (33).
Reagents. Monoclonal antibodies specific for human IgG subclasses were HP
6069 (anti-IgG1) used in polyclonal IgG1 determination and kindly provided by
R. G. Hamilton, Johns Hopkins University, Baltimore, Md. HP 6001 (anti-IgG1),
HP 6002 (anti-IgG2), HP 6047 (anti-IgG3), HP 6023 (anti-IgG4), and HP 6029
(anti-IgE) prepared at the Centers for Disease Control and Prevention, Atlanta,
Ga., were a gift from the late C. B. Reimer. The specificity, evaluation, and
performance characteristics of these antibodies have been described in detail
elsewhere (13, 14, 21). Goat anti-human IgG (Fc specific) and goat anti-mouse
IgG (heavy plus light chain specific) conjugated to alkaline phosphatase were
purchased (Jackson Laboratories, Westgrove, Pa.) and diluted according to the
manufacturer’s recommendations. Preparation of purified rabbit anti-human IgE
has been described in detail previously (9); the antibody was obtained by immunizing rabbits with the Fc fragments of human IgE myeloma, affinity purified over
an IgE-Sepharose column and rendered Fcε specific by sequential passage over
affinity columns of insolubilized IgG and F(ab9)2 fragments of human myeloma
IgE.
Quantitation of IgE, IgM, IgG, and IgG subclasses to M. tuberculosis CF. IgG
subclasses were quantitated by a slightly modified method as described previously for filarial antigens (13). Briefly, Immulon 4 plates (Dynatech, Alexandria,
Va.) were coated with 100 ml of M. tuberculosis CF at 1 mg/ml in carbonate buffer,
pH 9.6, for 2 h at 378C and then overnight at 48C. Phosphate-buffered saline
(PBS) containing 5% bovine serum albumin (BSA) was added for 2 h at 378C to
block free sites. One hundred microliters of sera diluted in PBS containing 0.05%
Tween 20 and 1.0% BSA was added and incubated for 2 h at 378C and then
overnight at 48C. Monoclonal antibodies specific for each of the IgG subclasses
and IgE were added at saturating concentrations of 1:1,000 for HP 6001, HP
6002, HP 6029, and HP 6047 and 1:500 for HP 6023 and further incubated
overnight at 48C. Alkaline phosphatase-labeled goat anti-mouse IgG was incubated for 2 h at 378C. The plates were finally developed with alkaline phosphatase substrate. Each incubation was followed by three washes with PBS
containing 0.05% Tween 20 to remove unbound protein. A serum pool containing high titers of antibody to M. tuberculosis CF was prepared and assigned
arbitrary units of activity as described in Results and used as a reference calibrator. All test sera were assayed at a minimum of 3 dilutions, and the activity
was expressed in units relative to the serum pool for IgG1 to IgG3 subclasses. For
IgG4 and IgE antibodies, all sera were run at a dilution of 1:10 in a single assay
and the results are expressed as optical density readings without converting into
units of activity.
Quantitation of polyclonal IgG subclasses. The concentration of polyclonal
IgG subclasses in serum was determined as detailed previously (14). Briefly,
Immulon 4 microtiter plates were coated at saturating concentrations of a 1:1,000
dilution of HP 6069, HP 6002, and HP 6047 and 1:100 dilution for HP 6023 and
incubated at 48C overnight. After the free sites were blocked with 5% BSA in
PBS for 2 h at 378C, the plates were incubated with sera. At least three serial
dilutions of test sera were run in each assay. A World Health Organization
reference serum (67/97) with known amounts of the four subclasses was run as a
standard. The sera were incubated for 2 h at 378C and subsequently overnight at
48C. The plates were probed with goat anti-human IgG conjugated to alkaline
phosphatase and subsequently developed with the appropriate substrate. Between each incubation the plates were washed three times to remove unbound
proteins. The reaction was stopped with 3 N NaOH, and optical density was read
at 410 nm in a microtiter plate reader (MR 600; Dynatech).
Quantitation of polyclonal IgE. Plates were coated with purified rabbit antihuman IgE at 2 mg/ml. Sera were incubated for 2 h at 378C and subsequently
overnight at 48C. Mouse monoclonal antibody HP 6029 was added at a 1:1,000
dilution and incubated overnight at 48C. Goat anti-mouse IgG conjugated to
alkaline phosphatase was used as the revealing probe (described above) and was
followed by the appropriate substrate. Between each step, the plates were
washed three times with PBS containing 0.05% Tween 20. An eight-point calibration curve was developed with a standard reference serum (myeloma PS; a
kind gift from T. Ishizaka) with known amounts of IgE as previously reported (9).
All test sera were run at a minimum of three serial dilutions. Values falling in the
midrange of the dose-response curve were to used to calculate the concentration
of IgE in test sera.
Statistical analysis. All statistical analyses were carried out using Microsoft
Excel, Cricket graph, and Statview software packages on a Macintosh microcomputer. The Student t test was carried out to assess the significance of differences
in antibody among patients and control groups. The Spearman rank correlation
test was used to determine the relationship between different parameters.
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indicator of TH1 responses, Spearman rank correlation was
used to analyze the relationship. Polyclonal IgG subclass responses showed a significant association with the respective
antigen-specific antibody responses (IgG1, rho 5 0.254, P ,
0.003; IgG2, rho 5 0.317, P , 0.0002; IgG3, rho 5 0.278, P ,
0.0013; IgG4, rho 5 0.211, P , 0.014) in patients with pulmonary tuberculosis. However, no significant association was observed between tuberculin skin test reaction size and either the
antigen-specific IgG1 (rho 5 0.089; P 5 0.338) or polyclonal
IgG1 (rho 5 0.083; P 5 0.369) antibodies, indicating that the
IgG1 response is independent of TH1 responses.
DISCUSSION
It has been suggested that similar to leprosy, tuberculosis is
a spectral disease with an inverse relationship between severity
of disease and cellular immune responses, as assessed by tuberculin skin tests and in vitro lymphocyte blastogenic responses, and a direct relationship with humoral responses (11,

17). These studies were based on small groups, and the patients
had been on variable lengths of ATT treatment. The major
strengths of our study are that we have used large group sizes,
particularly with the pulmonary patients, and the majority of
patients had received ,30 days of ATT treatment. Duration of
chemotherapy is an important consideration, since we were
interested in identifying immune profiles related to disease
establishment whereas ATT treatment can result in an alteration of the immune profile, particularly with respect to the
antibody responses. The most significant finding in the current
study was the presence of M. tuberculosis-specific IgG1 antibodies in patients with established disease without any correlation with the presence or absence of cellular responses. Specific IgG1 antibody was raised in all tuberculosis patients
irrespective of disease localization (lymph node versus pulmonary compartment) compared with that in healthy controls
(HC and EC). IgG1 antibody was not detected in HC despite
evidence of recent infection, as suggested by the significantly
raised IgM antibodies compared with those in healthy EC.
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FIG. 1. Dose-response curves for IgG, IgG1, IgG2, and IgG3 to M. tuberculosis CF. The reciprocal of serum dilution giving an optical density of ;0.1 was assigned
as units of activity per milliliter of neat serum: IgG, 16,000 U; IgG1, 3,200 U; IgG2, 6,400 U; and IgG3, 3,200 U. Calibration curves are shown as optical density (OD)
relative to units. A four-order polynomial fit used to assign units of antibody activity in individual test sera is shown.
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None of the other IgG subclasses or IgE antibodies showed
such consistent elevation in tuberculosis patients. One earlier
report using PPD antigens did not show similar elevation of
IgG1 in tuberculosis patients (15). One explanation may be
that PPD contains denatured antigens while CF is produced
without subjecting the proteins to denaturation (32). While T
cells are known to react equally well with native and denatured
proteins, antibody binding to denatured antigens can be decreased. This is substantiated by our previous observation that
IgM and IgG antibodies showed higher reactivity to CF compared with PPD, while in a lymphocyte proliferation assay,
PPD was consistently more active than CF in the same patient
groups (unpublished data). In leprosy, we have reported a
similar elevation of antigen-specific IgG1 and IgG3, and the
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strongest association of IgG1 antibodies was observed with
bacterial load rather than cellular responses (12).
In the murine system, switching of antibody responses from
IgM to one of the other isotypes is dependent on different
cytokines. Gamma interferon produced by TH1 cells induces
IgG2a and IgG3 in vitro (6, 28); interleukin-4 (IL-4) produced
by TH2 selectively stimulates IgG1 and IgE (7). The human
counterparts of murine IgG subclasses are based on similarities
in biological and functional activities. Murine IgG2a and
IgG2b and human IgG1 and IgG3 share the ability to fix
complement and bind to protein antigens (25). Murine IgG1
and human IgG4 are considered to be similar because of their
property of binding to mast cells. Murine IgG3 and human
IgG2 both recognize predominantly carbohydrate epitopes. In
humans, although TH1 and TH2 subsets have been identified
on the basis of their cytokine profiles (22, 23), detailed analysis
of the regulation of different isotypes and IgG subclasses is still
lacking. The most distinct requirement for isotype switching in
humans has been experimentally shown for IL-4, which upregulates IgG4 and IgE (16). In another study, there was no
relationship between IL-2, IL-4, IL-6, and gamma interferon
secreted by T-helper clones and their IgG subclass induction
pattern (4). Our studies suggest that IgG1 responses are independent of T-cell activation, since IgG1 antibodies do not show
any association with either skin test or lymphocyte blastogenic
responses which are suppressed in pulmonary tuberculosis but
not in tuberculous LN. Depressed PPD-stimulated blastogenesis in patients with pulmonary tuberculosis appears due, at
least in part, to a suppressive influence of monocytes (5, 26,
30). The mechanism of suppression involves direct stimulation
by PPD (34) of monocytes primed during the course of tuberculosis to produce suppressive predictors such as IL-2R (31)
and transforming growth factor b (29). It is of interest to
speculate that some of the mediators (cross-modulatory cytokines) overexpressed by activated monocytes in tuberculosis
could themselves contribute to the increased antibody levels by
promoting isotype switching and postswitch differentiation of B
cells and are not due to the presence or absence of activated T
cells. In the murine model recent data strongly suggest that the
monocyte-derived transforming growth factor b plays an important role in switching IgM responses to IgG2b (18).
No significant responses were observed with the IgG2 subclass antibodies in the patients compared with those in EC,
although IgG2 has been reported to be elevated in response to
the carbohydrate antigen lipoarabinomannan of M. tuberculosis (2) as well as to the PPD antigens in tuberculosis patients
(24). IgG2 preferentially recognizes T-independent carbohydrate antigens (1, 35). CF obtained in the log phase contains
relatively low levels of carbohydrates (32) such as lipoarabinomannan, and therefore, IgG2 antibodies may not be as reactive
with CF as with purified lipoarabinomannan. Furthermore,
carbohydrates are subclass antibody stable and may survive the
denaturation steps in the preparation of PPD, resulting in
denaturation of protein antigens but enrichment of carbohydrates, leading to lower reactivity with IgG1 but higher reactivity with IgG2. These observations raise an important issue of
bias that can be introduced by the use of different crude antigenic preparations. For T-cell-dependent antibody responses
to protein antigens, CF may be a more suitable antigen preparation than PPD.
Pulmonary patients also showed a trend towards higher concentrations of IgG3 and IgG4 antibodies, but these responses
did not achieve statistical significance. Despite the low levels of
M. tuberculosis IgE antibody detected, a significant difference
was observed in the pulmonary group compared with EC.
Similarly, patients with both pulmonary and lymph node in-
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FIG. 2. Comparison of antibody isotype (IgM, IgG, and IgE) responses to M.
tuberculosis CF in different groups. The number in each group is given in parentheses; horizontal bars indicate the 10th, 25th, 50th, 75th, and 90th percentiles
for each group. The Student t test was carried out to assess the significance of
differences between patient groups and EC (*, P , 0.05; **, P , 0.01; ***, P ,
0.001). OD, optical density.
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volvement also showed a trend towards higher responses in
IgG3, IgG4, and IgE subclasses, while patients with tuberculous LN alone did not show detectable responses in IgG3 and
IgG4.
M. tuberculosis-specific IgE antibodies also showed a significant difference between EC and pulmonary patients. Because
of the extremely low optical density readouts with IgE antibodies to M. tuberculosis, the significance of the difference
between EC and pulmonary patients remains questionable.
One reason for such low levels may be the blocking effect by M.
tuberculosis-specific antibodies of other IgG subclasses; further
studies need to be carried out to address this issue.
Polyclonal activation was also observed for the same IgG
isotypes (IgG1, IgG3, and IgE) for which antigen-specific antibodies were detected, suggesting that antigen-specific responses are related to polyclonal activation in these patients.
However, specific antibodies cannot be a reflection of polyclonal activation alone, since HC did not show specific antibodies despite polyclonal activation in all the relevant isotypes,
viz., IgG1, IgG3, and IgE. Whereas elevated IgE responses in
HC could be attributed to more frequent parasitic infections
due to lower socioeconomic background, elevation in IgG1 and

IgG3 is more difficult to explain. One explanation may be that
polyclonal responses precede antigen-specific responses. In the
case of the HC group, the intense exposure to mycobacteria
may initially lead to the activation of the innate arm of the
immune system, including IgM antibodies, NK cells, and gd T
cells, which are known to be activated by mycobacterial antigens (10). The lipopolysaccharide-like mycobacterial antigens
such as lipoarabinomannan and the cytokines secreted by the
activated cells may provide the permissive signals required for
polyclonal activation in HC (25). However, switching of antigen-specific IgM to IgG antibody requires additional signals
which are elaborated when the infection becomes patent. The
strong association observed between polyclonal and antigenspecific IgG subclass antibody responses suggests that initial
polyclonal expansion of B cells is a natural strategy for increasing the repertoire of antigen-specific B cells by the host.
Since IgG1 antibodies are associated only with disease establishment and not with infection alone, factors which result
in switching of IgM responses to IgG1 antibodies during infection may be critical to disease progression and need to be
further characterized. Obviously these observations need to be
extended to other extrapulmonary tuberculosis infections in
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FIG. 3. Comparison of IgG subclass antibodies to M. tuberculosis CF in each of the groups. All other parameters are same as described in the legend to Fig. 2.

a
IgE results are expressed as nanograms per milliliter. The Student t test was used to determine the significance of differences in antibodies among different groups. Significantly (P , 0.05) raised values compared
with EC values are underlined.

10.2 6 1.5 (3.6–20.8)
4.4 6 0.94 (0.89–12.8)
1.57 6 0.33 (0.32–4.2)
0.98 6 0.25 (0.13–3.36)
2,002 6 844 (35–10,000)
8.5 6 0.57 (3.76–24.0)
3.59 6 0.27 (1.1–9.6)
1.52 6 0.16 (0.5–6.1)
1.12 6 0.16 (0.06–5.7)
2,809 6 932 (5.6–37,500)
7.03 6 0.73 (2.0–18.0)
2.36 6 0.34 (0.07–7.2)
1.31 6 0.18 (0.32–3.2)
0.74 6 0.18 (0.02–4.8)
1,863 6 687 (40–14,000)
IgG1
IgG2
IgG3
IgG4
IgE

5.96 6 0.61 (1.8–13.86)
2.91 6 0.33 (0.55–5.52)
0.84 6 0.12 (0.28–2.17)
0.72 6 0.15 (0.05–2.60)
506 6 192 (8.0–3,900)

7.48 6 1.31 (2.44–16.8)
2.37 6 0.50 (0.4–5.6)
1.35 6 0.28 (0.43–3.04)
0.76 6 0.36 (0.11–4.16)
954 6 625 (80–5,096)

8.93 6 2.08 (6.0–12.8)
3.17 6 1.31 (1.6–6.0)
1.4 6 0.49 (0.8–2.4)
0.77 6 0.32 (0.32–1.28)
2,040 6 2,759 (35–9,000)

PAD (n 5 30)
PMD (n 5 105)
LN/P (n 5 6)
LN (n 5 23)
HC (n 5 59)
EC (n 5 51)
Isotype
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which skin test anergy has been observed in a high percentage
of patients and samples for microscopy and culture are difficult
to obtain. For diagnostic purposes the presence of specific
IgG1 could be a useful adjunct marker of disease.
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